NeuroBo Pharmaceuticals Total Assets 1970-1969 | MTVA

NeuroBo Pharmaceuticals total assets from 1970 to 1969. Total assets can be defined as the sum of all assets on a company's balance sheet.
NeuroBo Pharmaceuticals Annual Total Assets
(Millions of US $)
NeuroBo Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.022B $0.000B
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
Stock Name Country Market Cap PE Ratio
China Green Agriculture (ENFY) China $0.026B 0.00
Vista Outdoor (GEAR) United States $0.000B 0.00
CareMax (CMAXQ) United States $0.000B 0.00